A citation-based method for searching scientific literature

Sophie Tezenas du Montcel, Perrine Charles, Pascale Ribai, Cyril Goizet, Alice Le Bayon, Pierre Labauge, Lucie Guyant-Maréchal, Sylvie Forlani, Celine Jauffret, Nadia Vandenberghe, Karine N'guyen, Isabelle Le Ber, David Devos, Carlo-Maria Vincitorio, Mario-Ubaldo Manto, François Tison, Didier Hannequin, Merle Ruberg, Alexis Brice, Alexandra Durr. Brain 2008
Times Cited: 60







List of co-cited articles
448 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Scale for the assessment and rating of ataxia: development of a new clinical scale.
T Schmitz-Hübsch, S Tezenas du Montcel, L Baliko, J Berciano, S Boesch, C Depondt, P Giunti, C Globas, J Infante, J-S Kang,[...]. Neurology 2006
81

SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia.
T Schmitz-Hübsch, P Giunti, D A Stephenson, C Globas, L Baliko, F Saccà, C Mariotti, M Rakowicz, S Szymanski, J Infante,[...]. Neurology 2008
88
53

Responsiveness of different rating instruments in spinocerebellar ataxia patients.
T Schmitz-Hübsch, R Fimmers, M Rakowicz, R Rola, E Zdzienicka, R Fancellu, C Mariotti, C Linnemann, L Schöls, D Timmann,[...]. Neurology 2010
97
41

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.
P Trouillas, T Takayanagi, M Hallett, R D Currier, S H Subramony, K Wessel, A Bryer, H C Diener, S Massaquoi, C M Gomez,[...]. J Neurol Sci 1997
908
33

A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3).
C Kieling, C R M Rieder, A C F Silva, J A M Saute, C R Cecchin, T L Monte, L B Jardim. Eur J Neurol 2008
45
42

Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Heike Jacobi, Kathrin Reetz, Sophie Tezenas du Montcel, Peter Bauer, Caterina Mariotti, Lorenzo Nanetti, Maria Rakowicz, Anna Sulek, Alexandra Durr, Perrine Charles,[...]. Lancet Neurol 2013
115
28

Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
T Schmitz-Hübsch, M Coudert, P Bauer, P Giunti, C Globas, L Baliko, A Filla, C Mariotti, M Rakowicz, P Charles,[...]. Neurology 2008
174
26

Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Heike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, Paola Giunti, Arron Cook, Robyn Labrum, Michael H Parkinson, Alexandra Durr, Alexis Brice, Perrine Charles,[...]. Lancet Neurol 2015
133
26

Quantitative assessment of the evolution of cerebellar signs in spinocerebellar ataxias.
Ellis Chan, Perrine Charles, Pascale Ribai, Cyril Goizet, Cecilia Marelli, Carlo-Maria Vincitorio, Alice Le Bayon, Lucie Guyant-Maréchal, Nadia Vandenberghe, Mathieu Anheim,[...]. Mov Disord 2011
21
66

The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.
H Jacobi, P Bauer, P Giunti, R Labrum, M G Sweeney, P Charles, A Dürr, C Marelli, C Globas, C Linnemann,[...]. Neurology 2011
126
23

Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients.
Tanja Schmitz-Hübsch, Sophie Tezenas du Montcel, Laszlo Baliko, Sylvia Boesch, Sara Bonato, Roberto Fancellu, Paola Giunti, Christoph Globas, Jun-Suk Kang, Berry Kremer,[...]. Mov Disord 2006
97
20

Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument.
H Jacobi, M Rakowicz, R Rola, R Fancellu, C Mariotti, P Charles, A Dürr, M Küper, D Timmann, C Linnemann,[...]. Cerebellum 2013
68
20

Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
Jörg B Schulz, Johannes Borkert, Stefanie Wolf, Tanja Schmitz-Hübsch, Maryla Rakowicz, Caterina Mariotti, Ludger Schöls, Dagmar Timmann, Bart van de Warrenburg, Alexandra Dürr,[...]. Neuroimage 2010
115
20

Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
Kathrin Reetz, Ana S Costa, Shahram Mirzazade, Anna Lehmann, Agnes Juzek, Maria Rakowicz, Romana Boguslawska, Ludger Schöls, Christoph Linnemann, Caterina Mariotti,[...]. Brain 2013
86
20

Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia.
Sophie Tezenas du Montcel, Perrine Charles, Cyril Goizet, Cecilia Marelli, Pascale Ribai, Carlo Vincitorio, Mathieu Anheim, Lucie Guyant-Maréchal, Alice Le Bayon, Nadia Vandenberghe,[...]. Arch Neurol 2012
40
30

Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.
S H Subramony, W May, D Lynch, C Gomez, K Fischbeck, M Hallett, P Taylor, R Wilson, T Ashizawa. Neurology 2005
208
16

Progression of ataxia in patients with Machado-Joseph disease.
Marcondes C França, Anelyssa D'Abreu, Anamarli Nucci, Fernando Cendes, Iscia Lopes-Cendes. Mov Disord 2009
30
33


Ataxia rating scales--psychometric profiles, natural history and their application in clinical trials.
Jonas Alex Morales Saute, Karina Carvalho Donis, Carmen Serrano-Munuera, David Genis, Luís Torres Ramirez, Pilar Mazzetti, Luis Velázquez Pérez, Pilar Latorre, Jorge Sequeiros, Antoni Matilla-Dueñas,[...]. Cerebellum 2012
75
16

Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.
Ludger Schöls, Peter Bauer, Thorsten Schmidt, Thorsten Schulte, Olaf Riess. Lancet Neurol 2004
672
15

Progression rate of neurological deficits in a 10-year cohort of SCA3 patients.
Laura Bannach Jardim, Lisiane Hauser, Christian Kieling, Jonas Alex Morales Saute, Renan Xavier, Carlos Roberto Mello Rieder, Thais Lampert Monte, Suzi Camey, Vanessa Bielefeld Leotti Torman. Cerebellum 2010
35
25

Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
Silvia Romano, Giulia Coarelli, Christian Marcotulli, Luca Leonardi, Francesca Piccolo, Maria Spadaro, Marina Frontali, Michela Ferraldeschi, Maria Chiara Vulpiani, Federica Ponzelli,[...]. Lancet Neurol 2015
108
15

Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.
Tetsuo Ashizawa, Karla P Figueroa, Susan L Perlman, Christopher M Gomez, George R Wilmot, Jeremy D Schmahmann, Sarah H Ying, Theresa A Zesiewicz, Henry L Paulson, Vikram G Shakkottai,[...]. Orphanet J Rare Dis 2013
78
15

A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3.
Rachel P Guimarães, Anelyssa D'Abreu, Clarissa L Yasuda, Marcondes C França, Beatriz H B Silva, Fabio A M Cappabianco, Felipe P G Bergo, Iscia T Lopes-Cendes, Fernando Cendes. Mov Disord 2013
55
16

Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS.
Jeremy D Schmahmann, Raquel Gardner, Jason MacMore, Mark G Vangel. Mov Disord 2009
126
13

In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.
Isaac M Adanyeguh, Pierre-Gilles Henry, Tra M Nguyen, Daisy Rinaldi, Celine Jauffret, Romain Valabregue, Uzay E Emir, Dinesh K Deelchand, Alexis Brice, Lynn E Eberly,[...]. Mov Disord 2015
45
17

Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3.
Gerson da Silva Carvalho, Jonas Alex Morales Saute, Clarissa Branco Haas, Vitor Rocco Torrez, Andressa Wigner Brochier, Gabriele Nunes Souza, Gabriel Vasata Furtado, Tailise Gheno, Aline Russo, Thais Lampert Monte,[...]. Cerebellum 2016
19
42

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Adriano M de Assis, Jonas Alex Morales Saute, Aline Longoni, Clarissa Branco Haas, Vitor Rocco Torrez, Andressa Wigner Brochier, Gabriele Nunes Souza, Gabriel Vasata Furtado, Tailise Conte Gheno, Aline Russo,[...]. Front Neurol 2017
31
25

Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
L Guerrini, F Lolli, A Ginestroni, G Belli, R Della Nave, C Tessa, S Foresti, M Cosottini, S Piacentini, F Salvi,[...]. Brain 2004
78
11

The natural history of degenerative ataxia: a retrospective study in 466 patients.
T Klockgether, R Lüdtke, B Kramer, M Abele, K Bürk, L Schöls, O Riess, F Laccone, S Boesch, I Lopes-Cendes,[...]. Brain 1998
230
11

Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
G Ristori, S Romano, A Visconti, S Cannoni, M Spadaro, M Frontali, F E Pontieri, N Vanacore, M Salvetti. Neurology 2010
106
11

Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.
Lisa S Friedman, Jennifer M Farmer, Susan Perlman, George Wilmot, Christopher M Gomez, Khalaf O Bushara, Katherine D Mathews, S H Subramony, Tetsuo Ashizawa, Laura J Balcer,[...]. Mov Disord 2010
79
11

Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6.
Christoph Globas, Sophie Tezenas du Montcel, Laslo Baliko, Syliva Boesch, Chantal Depondt, Stefano DiDonato, Alexandra Durr, Alessandro Filla, Thomas Klockgether, Caterina Mariotti,[...]. Mov Disord 2008
79
11

Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.
Kathrin Reetz, Imis Dogan, Ana S Costa, Manuel Dafotakis, Kathrin Fedosov, Paola Giunti, Michael H Parkinson, Mary G Sweeney, Caterina Mariotti, Marta Panzeri,[...]. Lancet Neurol 2015
105
11

A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease.
Jonas Alex Morales Saute, Raphael Machado de Castilhos, Thais Lampert Monte, Artur Francisco Schumacher-Schuh, Karina Carvalho Donis, Rui D'Ávila, Gabriele Nunes Souza, Aline Dutra Russo, Gabriel Vasata Furtado, Tailise Conte Gheno,[...]. Mov Disord 2014
48
14

Spinocerebellar ataxias in Brazil--frequencies and modulating effects of related genes.
Raphael Machado de Castilhos, Gabriel Vasata Furtado, Tailise Conte Gheno, Paola Schaeffer, Aline Russo, Orlando Barsottini, José Luiz Pedroso, Diego Z Salarini, Fernando Regla Vargas, Maria Angélica de Faria Domingues de Lima,[...]. Cerebellum 2014
73
11

Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study.
Anelyssa D'Abreu, Marcondes C França, Clarissa L Yasuda, Bruno A G Campos, Iscia Lopes-Cendes, Fernando Cendes. J Neuroimaging 2012
57
12

Comparison of cerebellar ataxias: A three-year prospective longitudinal assessment.
Yi-chung Lee, Yi-chu Liao, Po-shan Wang, I-Hui Lee, Kon-ping Lin, Bing-wen Soong. Mov Disord 2011
43
16

Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study.
Luis Velázquez-Pérez, Roberto Rodríguez-Labrada, Nalia Canales-Ochoa, Jacqueline Medrano Montero, Gilberto Sánchez-Cruz, Raúl Aguilera-Rodríguez, Luis E Almaguer-Mederos, José M Laffita-Mesa. Lancet Neurol 2014
58
12

Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study.
Kathrin Reetz, Imis Dogan, Ralf-Dieter Hilgers, Paola Giunti, Caterina Mariotti, Alexandra Durr, Sylvia Boesch, Thomas Klopstock, Francisco Javier Rodriguez de Rivera, Ludger Schöls,[...]. Lancet Neurol 2016
66
11

Oculomotor deficits in spinocerebellar ataxia type 3: Potential biomarkers of preclinical detection and disease progression.
Chao Wu, Ding-Bang Chen, Li Feng, Xiang-Xue Zhou, Ji-Wei Zhang, Hua-Jing You, Xiu-Ling Liang, Zhong Pei, Xun-Hua Li. CNS Neurosci Ther 2017
24
29

Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study.
Carlo Wilke, Friedemann Bender, Stefanie N Hayer, Kathrin Brockmann, Ludger Schöls, Jens Kuhle, Matthis Synofzik. J Neurol 2018
37
18

Friedreich and dominant ataxias: quantitative differences in cerebellar dysfunction measurements.
Audrey Tanguy Melac, Caterina Mariotti, Antoine Filipovic Pierucci, Paola Giunti, Javier Arpa, Sylvia Boesch, Thomas Klopstock, Jennifer Müller Vom Hagen, Thomas Klockgether, Katrin Bürk,[...]. J Neurol Neurosurg Psychiatry 2018
11
63

How is disease progress in Friedreich's ataxia best measured? A study of four rating scales.
M C Fahey, L Corben, V Collins, A J Churchyard, M B Delatycki. J Neurol Neurosurg Psychiatry 2007
62
10

Measuring Friedreich ataxia: complementary features of examination and performance measures.
D R Lynch, J M Farmer, A Y Tsou, S Perlman, S H Subramony, C M Gomez, T Ashizawa, G R Wilmot, R B Wilson, L J Balcer. Neurology 2006
124
10

Comparison of three clinical rating scales in Friedreich ataxia (FRDA).
Katrin Bürk, Ulrike Mälzig, Stefanie Wolf, Suzette Heck, Konstantinos Dimitriadis, Tanja Schmitz-Hübsch, Sascha Hering, Tobias M Lindig, Verena Haug, Dagmar Timmann,[...]. Mov Disord 2009
87
10

Reliability and validity of the scale for the assessment and rating of ataxia: a study in 64 ataxia patients.
Anja Weyer, Michael Abele, Tanja Schmitz-Hübsch, Beate Schoch, Markus Frings, Dagmar Timmann, Thomas Klockgether. Mov Disord 2007
109
10

Self-rated health status in spinocerebellar ataxia--results from a European multicenter study.
Tanja Schmitz-Hübsch, Mathieu Coudert, Paola Giunti, Christoph Globas, Laszlo Baliko, Roberto Fancellu, Caterina Mariotti, Alessandro Filla, Maryla Rakowicz, Perrine Charles,[...]. Mov Disord 2010
47
12

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.
Y Kawaguchi, T Okamoto, M Taniwaki, M Aizawa, M Inoue, S Katayama, H Kawakami, S Nakamura, M Nishimura, I Akiguchi. Nat Genet 1994
10

Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n.
L B Jardim, M L Pereira, I Silveira, A Ferro, J Sequeiros, R Giugliani. Arch Neurol 2001
110
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.